Objectives: Chordoma is a rare malignant bone tumour arising from notochordal remnants. Long non-coding RNA LOC554202, as the host gene of miR-31, contributes to various cancer developments. However, little is known about the biological function of LOC554202 in chordoma. Here, the relationship between LncRNA LOC554202, miR-31 and EZH2 was elucidated in chordoma. 
| INTRODUCTION
Chordoma is a rare bone tumour arising from malignant transformation of cellular remnants of the embryonic notochord, 1 is characterized as highly recurrent, aggressive and locally invasive, and occurs most commonly at the sacrococcygeal and skull base region. 2, 3 The tumour predominantly affects older male adults. 4 To date, surgical resection is the first choice for the treatment of chordoma, which is highly resistant to chemotherapy and radiotherapy. 5 However, there is still frequent local recurrence and eventual metastasis after surgical measures for. 6, 7 Therefore, knowledge about the molecular biology process underlying chordoma progression will help us better understand this disease and develop effective targeted therapies.
According to the genome data, the human transcriptome consists largely of non-coding RNAs (ncRNAs), which are defined as endogenous regulatory RNAs and broadly classified into short ncRNAs and long ncRNA (LncRNAs) based on size. LncRNA-p21 can enhance PTEN expression by competitively binding miR-181b in liver fibrosis. 17 LncRNA loc554202 (LOC554202) is a non-protein-coding gene located on human chromosome 9p21.3 and was recently reported to be downregulated in colorectal cancer, 18 but overexpressed breast cancer cells, 19 suggesting that LOC554202 might function as anti-oncogene or oncogene similar to protein-coding genes in these types of cancers. Studies have shown that LOC554202 is the host gene of miR-31 and regulates its transcriptional level, 19, 20 as further verified in triple-negative breast cancer. 21 Most recently, Bayrak et al found that miR-31 was significantly downregulated in chordomas and that its overexpression suppressed chordoma cancer cell proliferation by inducing apoptosis, 22 which indicated that miR-31 might be closely correlated with chordoma progression. These results further prompted us to investigate the biological functions of LOC554202 and the relationship between LOC554202 and miR-31 in chordoma.
In the present study, we examined the expression of LOC554202 and miR-31 in chordoma tissues and performed lossof-function and gain-of-function experiments in chordoma cell lines and evaluated proliferation, migration, invasion, and apoptosis. We also elucidated the molecular mechanisms underlying the relationship between LOC554202 and miR-31, which will aid us to find potential therapeutic targets in the treatment of patients with chordoma.
| MATERIALS AND METHODS

| Chordoma tissues samples
A total of 20 pairs of fresh chordoma and normal tissue specimens were obtained from patients who had undergone surgical resection of chordoma in the Affiliated Hospital of Guilin Medical University. None of the enrolled patients had received any chemotherapy or radiotherapy before surgical excision of the tumour lesion. Before participation in this study, each patient signed written informed consent forms. This study was approved by the hospital ethics committee of the Affiliated
Hospital of Guilin Medical University.
| Cell lines and transfection
The chordoma cell lines, U-CH1and JHC7, were obtained from the American Type Culture Collection (Manassas, VA). U-CH1 cells were cultured in IMDM-RPMI media (4:1) supplemented with 10% FBS and 1% penicillin-streptomycin. JHC7 cells were grown in DMEM media containing 10% FBS and 1% penicillin-streptomycin. These two cell lines were maintained in a humidified 5% CO 2 -enriched atmosphere at 37°C.
To construct the LOC554202 and RNF144B knockdown cell models, U-CH1 and JHC7 cells were transfected with siRNAs against LOC554202 and RNF144B to generate U-CH1/siLOC554202, U-CH1/siRNF144B, JHC7/siLOC554202, and JHC7/siRNF144B, respectively. For overexpression of miR-31, U-CH1 and JHC7 cells were transfected with miR-31 mimics, with negative control (NC) as control. All transfections were carried out using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's instruction.
All of the siRNAs and miR-31 mimics used in the study were synthesized by GenePharma Company (Shanghai, China).
| Quantitative real-time PCR (qRT-PCR) analysis
Total RNA was extracted from tissues and cells using TRIZOL reagent (Invitrogen, Carlsbad, CA, Life Technologies, Carlsbad, CA) according to the manufacturer's protocols. For qRT-PCR, 1 μg of total RNA was reverse transcribed to cDNA using Reverse Transcription Kit (Takara, Dalian, China). Gene expression was determined using Fast Real-time PCR 7500 System (Applied Biosystems, Foster City, CA). The PCR reaction was set for 50°C for 2 minutes, followed by 40 cycles of 95°C for 15 seconds, then 60°C for 1 minute. GAPDH was amplified as the internal control for LOC554202 and mRNAs. U6 snRNA was used to normalize the relative abundance of miR-31. The expression levels (2-ΔΔCt) of LOC554202, mRNAs, and miR-31 were calculated as described previously. 23 The primer pair that was used is shown in Table 1 .
| Fluorescence in situ hybridization (FISH)
Probes for MIR31HG-FISH were purchased from Ribobio Company (Guangzhou, China), U6 and 18S were used as cytoplasmic and nuclear positive control. Frozen sections of tumour tissues were briefly thawed, permeabilised with 0.5% TX in PBS for 8 minutes on ice, fixed in 4% formaldehyde/5% acetic acid/0.14 M NaCl for 18 minutes at room temperature, washed in PBS, dehydrated in 70%-100% ethanol series and air-dried for the hybridization with MIR31HG probes according to the the manufacturer's protocols.
The coverslips were mounted onto the glass slides with neutral gum and observed by FV10i confocal microscope (OLYMPUS, Japan).
| EdU flow cytometry assay
To measure cell proliferation rates, EdU incorporation experiments were performed using the Cell Light™ EdU Apollo 
| Colony formation assay
To evaluate monolayer colony formation, stably transfected U-CH1 and JHC7 cells from different groups (control, NC, miR-31, or siLOC554202) were plated into six-well plates at a density of 600 cells per well and incubated for 7 days. Then cells were fixed with paraformaldehyde and stained with 1% crystal violet (Beyotime) as previously reported. 24 The colonies that were formed (more than 50 cells per colony) were observed using Image-Pro Plus 6.0 software (Media Cybernetics, MD) and manually counted under light microscopy. Each experiment was performed in triplicate and repeated three times.
| Hoechst staining assay
Cells were cultured in six-well plates for 48 hours after transfection and incubated with Hoechst 33 342 (5 μg/mL, Sigma, St. Louis, MO)
for 10 minute at room temperature. Following washing with 0.5%
TritonX-100 in PBS, the changes in nuclear morphology were observed under a fluorescence microscope (OLYMPUS, Tokyo, Japan).
Each experiment was performed in triplicate and repeated three times.
| Cell migration and invasion assay
Cell migration/invasion was observed using Transwell chambers 
| Tumour xenograft model and tumour formation assay
Stably transfected U-CH1 and JHC7 cells (4 × 10 6 cells/mouse, 0.2 mL) were subcutaneously injected into 5-week-old male NOD-SCID nude mice provided from Shanghai Laboratory Animals Center of the Chinese Academy of Sciences (Shanghai, China). Tumour volumes were examined and calculated every 7 days using the following formula: 0.5 × length × width 2 . This study was approved by the
Committee on the Ethics of Animal Experiments of the Affiliated
| RNA pull down assay
The expression vector pcDNA3.0-LOC554202 and pcDNA3.0-GAPDH were first labelled with biotin-UTP via in vitro transcription. Biotinlabelled LOC554202 and GAPDH were incubated with HEK293 cell pellets overexpressing flag-EZH2. Then a total of 20 μL washed High
Capacity Streptavidin Agarose Beads (Thermo, Rockford, IL) was added to the above mixture and incubated for 1 hour. After three washes in salt wash buffer, the beads were boiled in SDS buffer. Subsequently, EZH2 protein was detected using anti-Flag by Western blot.
Recombinant GST-EZH2 was purified using GST-agarose reaction and incubated for 30 minutes, then washed according to the above method. All binding reactions and washes were carried out in room temperature. Retrieved protein was also determined using Western blot.
| RNA immunoprecipitation (RIP) assay
RNA immunoprecipitation was used to investigate whether ribonucleoprotein complex contained LOC554202 and its potential binding protein EZH2 in chordoma cells using the Magna RIPRNAbinding protein immunoprecipitation kit (Millipore) according to the manufacturer's instructions. qRT-PCR was performed to detect the co-precipitated RNAs with the total RNAs as the input controls.
| Luciferase activity assay
The 3′-UTR sequence of RNF144B containing the binding site of 
| Western blot assay
| Immunohistochemistry
Tissue expression of EZH2 protein was examined using immunohistochemistry. Briefly, tissues were fixed in 10% formaldehyde and cut into 4-μm-thick slices. They were then deparaffinized in xylene and rehydrated in graded alcohol. The sections were washed and then immunostained using DAB plus kit (Maixin, Fuzhou, China) after incubating with primary antibody (1:5000, Sigma, St. Louis, MO) at 4°C overnight. Staining under 20% of the tissue or no staining was included in the negative group, while the others belonged to the positive groups.
| Statistical analysis
All data were shown as mean ± SD. All statistical analyses were performed using SPSS 17.0 software. Student's t test was used to determine the statistical significance between two group in vitro and in vivo experiments. A two-tailed value of P < .05 was considered statistically significant.
| RESULTS
| Expression of LOC554402 and miR-31 in chordoma tissues
qRT-PCR assay was used to determine the expression of LOC554202 and miR-31 in 20 paired clinical chordoma and non-tumour tissues. As shown in Figure 1A , the mRNA levels of 
| LOC554202/miR-31 affects cell proliferation and apoptosis in chordoma
To investigate the biological functions of LOC554402 and miR-31 in chordoma, we then selected two chordoma cell lines, U-CH1 and JHC7 to carry out loss-of-function and gain-of-function experiments. As depicted in Figure 2A F I G U R E 1 Loc554202 and miR-31 were aberrantly expressed in chordoma tissues. Quantitative real-time PCR (qRT-PCR) was performed to measure the mRNA levels of LOC554202, and its expression pattern was determined by FISH (A) and miR-31 (B). The correlation between LOC554202 and miR-31 was also analyzed (C)
The effects of LOC554202 and miR-31 on chordoma cell proliferation and apoptosis in vitro. Chordoma cells were transfected with siLOC554202, miR-31 mimics, or empty vector control. A, EdU flow cytometry was used to analyze the percentage of EdU positive cells in U-CH1 and JHC7 cells after transfection with siLOC554202, miR-31 mimics, NC, or empty vector, respectively. B, A colony formation assay was performed to determine the role of LOC554202 or miR-31 in cell proliferation in U-CH1 and JHC7 cells. C, Hoechst staining assay was performed to determine the number of cells with condensed and fragmented nuclei, indicating cell apoptosis. **P < .01
| LOC554202/miR-31 affects cell migration and invasion in chordoma by altering EMT expression
We further assessed the effects of LOC554202 and miR-31 on cell migration and invasion, which are key determinants of malignant progression and metastasis. Using a Transwell system, we found the migratory and invasive ability of U-CH1 and JHC7 cells was significantly decreased following siLOC554202 or miR-31 mimics transfection ( Figure 3A ). Then we detected the expression of classical epithelial-mesenchymal transition (EMT) markers, including cytokeratin, E-cadherin, N-cadherin, and vimentin by qRT-PCR and Western blot analysis. As shown in Figure 3B , the mRNA levels of cytokeratin and E-cadherin were dramatically elevated, while mRNA levels of Ncadherin and vimentin were significantly decreased in LOC554202 knockdown or miR-31 overexpressed chordoma cells (P < .01, P < .001). Consistent with the qRT-PCR results, the protein levels of EMT markers presented similar trends in U-CH1 and JHC7 cells following siLOC554202 or miR-31 mimics transfection ( Figure 3C ).
These results further indicated that LOC554202/miR-31 altered cell migratory and invasive ability by regulating the EMT process of chordoma cells.
| LOC554202 silenced miR-31 expression by directly recruiting EZH2
Previous research findings have indicated that lncRNAs play an important role in regulating tumour cell growth via binding to enhancer of zeste homolog-2 (EZH2) in many cancers. 25, 26 Thus we analyzed the interaction between LOC554202 and EZH2 by RNA pull down and RIP assay. As shown in Figure 4A , EZH2 was specifically retrieved by purified biotinylated LOC554202 RNA in HEK293 cells transfected with a Flag-EZH2 expressing vector. Furthermore, purified GST-EZH2 was observed to be bound to biotinylated LOC554202 in vitro ( Figure 4B ).
Furthermore, results of RIP assay revealed that LOC554202 RNA was more highly enriched by antibody against EZH2 in chordoma cells compared with the IgG control ( Figure 4C ). In summary, these results demonstrated a direct interaction between LOC554202 and EZH2.
To further confirm these results, the effects of LOC554202 overexpression on EZH2 and miR-31 were analyzed using qRT-PCR, which
showed that overexpression of LOC554202 significantly increased the relative mRNA level of EZH2 ( Figure 4D ), and the tumour tissues also showed higher expression of EZH2 compared with relative normal tissue ( Figure 4E ). The expression of miR-31 was inhibited by
The effects of LOC554202 and miR-31 on chordoma cell migration and invasion in vitro. A, Transwell assay was used to determine cell migratory and invasive ability in U-CH1 and JHC7 cells following siLOC554202 or miR-31 mimics transfection. B, The mRNA levels of cytokeratin, E-cadherin, N-cadherin, and vimentin were detected by qRT-PCR. *P < .05, **P < .01 vs NC or control, Student's t test. C, The protein levels of cytokeratin, E-cadherin, N-cadherin, and vimentin were evaluated by Western blot overexpression of LOC554202, but could be restored by the EZH2 inhibitor, 3-deazaneplanocin A ( Figure 4F ). These data suggested that LOC554202 was negatively correlated with miR-31 expression by recruiting EZH2.
| RNF144B was a target of miR-31
TargetScan 6.2 and miRanda were used to predict the target of miR-31.
As shown in Figure 5A , RNF144B was found to be a novel oncogene F I G U R E 4 LOC554202 silenced miR-31 expression by directly recruiting EZH2. A, Western blot of EZH2 protein bound to in vitro transcribed biotinylated LOC554202 incubated with extracts of 293T cells that were transfected with Flag-EZH2 vector. B, In vitro transcribed biotinylated LOC554202 retrieved purified GST-EZH2 but not GST. C, RIP experiments were performed using an antibody against EZH2 on extracts from chordoma cells. Protein immunoprecipitated from cell extracts by EZH2 antibody or IgG was detected by Western blot analysis. Purified RNA was used for qRT-PCR. D, The expression of LOC554202 and EZH2 were determined in chordoma cells following LOC554202 knockdown. E, Immunohistochemistry of EZH2 in tumor tissue and normal tissue. F, The expression of miR-31 mRNA was measured in chordoma cells following LOC554202 knockdown with or without 3-deazaneplanocin A treatment; **P < .01 versus pcDNA3.0 or control, Student's t test F I G U R E 5 RNF144B was a direct target of miR-31 in chordoma. A, Bioinformatic analysis identified a potential miR-31 target site in the 3′-UTR of RNF144B. B, 293T cells were cotransfected with wild-type or mutated RNF144B 3′-UTR reporter constructs and miR-31 mimics or negative control. Firefly luciferase activity was normalized to Renilla luciferase activity. **P < .01 versus NC, Student's t test. C, The mRNA level of RNF144B was determined in chordoma tissues and normal tissues using qRT-PCR analysis. ***P < .001 versus normal tissues, Student's t test. D and E, The mRNA and protein expression of RNF144B were measured in U-CH1 cells transfected with miR-31 mimics or NC. *P < .05, Student's t test targeted by miR-31. To examine whether miR-31 directly binds to the 3′-UTR of RNF144B, we used the Luciferase Reporter Assay after transfecting 293T cells with psiCHECKTM-2-RNF144B-3′-UTR together with miR-31 mimics, mutational miR-31, or NC. The results indicated that luciferase activity was decreased when psiCHECKTM-2-RNF144B-3′-UTR was cotransfected with miR-31 mimics, but was unchanged with mutational miR-31 mimics ( Figure 5B , P < .01).
Furthermore, we found that the expression of RNF144B mRNA was significantly upregulated in chordoma tissues, which suggested it might be a novel oncogene in chordoma ( Figure 5C , P < .001). In addition, overexpression of miR-31 decreased RNF144B expression, as determined by qRT-PCR ( Figure 5D , P < .01) and Western blot analysis ( Figure 5E ). These findings further supported that RNF144B was the target of miR-31.
| Knockdown of RNF144B suppressed cell proliferation and promoted apoptosis in chordoma
RNF144B has been shown to be overexpressed in chordoma, which is targeted by miR-31. To further investigate its role in chordoma, we performed loss-of-function experiments in U-CH1 and JHC7 cells.
As shown in Figure 6A , the positive fluorescence rate was signifi- 
| Knockdown of RNF144B inhibited cell migration and invasion by altering EMT expression
We next investigated the effect of RNF144B on chordoma cell migra- 
| DISCUSSION
Dysregulated expression of lncRNAs and miRs is frequently observed in various cancers, where they act as tumour suppressors or oncogenes. A previous study demonstrated that LOC554202, which is the host gene of miR-31, regulates breast cancer cell proliferation and migration. 19 At present, however, the molecular basis of the interaction between LOC554202 and miR-31 in chordoma is still unclear. Here, we aimed to investigate the involvement of LOC554202 and miR-31
and their biological functions in chordoma.
Our data showed that LOC554202 was significantly upregulated in chordoma tissues compared with normal tissues, accompanied by a concomitant decrease in miR-31 expression. We also observed that F I G U R E 7 Downregulation of RNF144B suppressed chordoma cell migration, invasion, and EMT. A, Transwell assays were used to investigate the changes in migratory and invasive ability of chordoma cell lines, U-CH1 and JHC7. B, qRT-PCR was used to detect cytokeratin, E-cadherin, N-cadherin, and vimentin expression in U-CH1 and JHC7 cells with siRNF144B, pcDNA 3.0-LOC554202 or NC. *P < .05, **P < .01, Student's t test. C, Western blot was used to detect cytokeratin, E-cadherin, N-cadherin, and vimentin expression in U-CH1 and JHC7 cells with siRNF144B downregulation of LOC554202 suppressed cell proliferation, impaired colony formation ability, promoted cell apoptosis in vitro. Furthermore, siRNA-mediated knockdown of LOC554202 decreased cell migration and invasion by chordoma cells through suppression of EMT expression, as revealed by elevated expression of E-cadherin and reduced expression of N-cadherin and vimentin. These findings were consistent with previous reports showing that LOC554202 promotes tumourigenesis in breast cancer 19 and lung cancer. 27 In addition, we also determined the function of miR-31 by performing gain-of-function experiments on chordoma cells. Similar to loss-of-function of LOC554202, overexpression of miR-31 inhibited cell proliferation, migration, and invasion, increased apoptosis in vitro, and suppressed tumour growth in vivo in chordoma; these findings were in agreement with the study of Bayrak and colleagues. 22 These results suggested that LOC554202 has oncogenic role, while miR-31 has tumour suppressive role in chordoma.
Although miR-31 is transcribed from the first intron of LOC554202 on human chromosome 9, 20 LOC554202 expression was negatively correlated with miR-31 expression in chordoma. We thus guessed that LOC554202 may have direct effects on its target genes, or act indirectly through specific LOC554202-interacting proteins. Further exploration identified EZH2 as the target gene of LOC554202 using RNA pull down and RIP assay, and RNF144B was identified as the target of miR-31 by the luciferase reporter assay. EZH2, a polycomb protein, has been found to be a tumour promoter frequently involved in variety of human cancers such as prostate cancer and breast cancer. 28, 29 Consistent with previous studies, the expression of EZH2 was significantly upregulated under the condition of LOC554202 overexpression. RNF144B, an E3 ubiquitination ligase, has been shown to be necessary for inflammasome responses in primary human macrophages. 30 Although the downstream regulation of RNF144B by miR-31 is not completely understood, we showed that RNF144B was remarkably upregulated in chordoma tissues and that its downregulation reduced cell proliferation, migration, and invasion, and promoted cell apoptosis in chordoma cells. These findings indicated that LOC554202 and miR-31 have different targets and play different roles in different pathways in chordoma progression.
F I G U R E 8
The effects of LOC554202 and miR-31 on tumour growth in a xenograft mouse model. A and C, The total visible tumours formed in siLOC554202, miR-31 mimics, NC or control groups, respectively. B and D, The tumour volumes were calculated every 7 days after inoculation. E, After knockdown of LOC554202, the expression of EZH2, miR-31, RNF144B, and EMT markers were estimated in tumour tissues. *P < .05, **P < .01 versus NC or control, Student's t test
In summary, this study examined the expression of LOC554202
and miR-31 and their biological function in chordoma. Furthermore, we concluded there might be a novel LOC554202/EZH2/miR-31/ RNF144B signalling cascade in chordoma. But the complexities of LOC554202 function may be beyond we imagined, and further analysis is needed.
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